NCT06499961

Brief Summary

The digital version of Holistic Healthy Life Education" (e2HLE) is a holistic, person-centric, multi-component and lifestyle modification intervention that we developed, alongside the WHO integrated care for older people (ICOPE) model and a home-based self-monitoring bio-signals system "Hera Leto". This randomized controlled trial aims to evaluate the effectiveness of e2HLE intervention for achieving weight loss and enhancing self-care and intrinsic capacity (i.e. psychological and mental wellbeing, vitality and nutritional health) as well as improving cardio-metabolic profiles (e.g. blood pressure and lipid profile) compared to usual care.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for not_applicable hypertension

Timeline
0mo left

Started Jun 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress98%
Jun 2024May 2026

First Submitted

Initial submission to the registry

May 7, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

June 22, 2024

Completed
23 days until next milestone

First Posted

Study publicly available on registry

July 15, 2024

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 21, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 21, 2026

Expected
Last Updated

July 15, 2024

Status Verified

July 1, 2024

Enrollment Period

1.7 years

First QC Date

May 7, 2024

Last Update Submit

July 7, 2024

Conditions

Keywords

healthy lifestyle

Outcome Measures

Primary Outcomes (1)

  • Weight loss

    Weight change from baseline to post-intervention (kg)

    3 months

Secondary Outcomes (21)

  • Intrinsic capacity

    3 months

  • Heart rate variability

    3 months

  • Waist circumstance

    3 months

  • Blood pressure

    3 months

  • Concentration of high density lipoprotein cholesterol (HDL)

    3 months

  • +16 more secondary outcomes

Study Arms (2)

digital version of Holistic Healthy Life Education (e2HLE)

EXPERIMENTAL
Behavioral: Digital version of Holistic Healthy Life Education

Waitlist-control

OTHER
Other: Waitlist control

Interventions

Participants need to attend a two-day workshop related to (1) health risk appraisal and self-care; (2) exercise, fitness and self-acupressure; (3) emotion and stress management; (4) the whole food plant-based (WFPB) diet; and (5) meditation and mindfulness practices, led by a multi-disciplinary team. Before the intervention commences, they will take pre-blood test and further receive the e2HLE with Hera Leto for three months. During the intervention, participants will attend (1) nine weekly workshops pertaining to WFPB diet, exercise, fitness and self-acupressure, and meditation and mindfulness and followed by weekly tele-counselling sessions; (2) three process evaluation practice sharing sessions in the format of focus group, making up a total of twelve sessions. The process evaluation practice sharing sessions will be audio-recorded; (3) mutual support networking platform will be held between case managers and participants within Hera Leto system.

digital version of Holistic Healthy Life Education (e2HLE)

usual care first, then switch to receive the intervention

Waitlist-control

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • aged 50 years old or above,
  • able to use internet and tablet;
  • education level of primary or above;
  • understand Chinese and speak Cantonese;
  • have central obesity (waist circumference: male \>90 cm, female \>80 cm) and two of the following: (a) hypertension (systolic blood pressure ≥130 or diastolic blood pressure ≥85 mmHg, or treatment of previously diagnosed hypertension), (b) hyperglycemia (fasting plasma glucose ≥100 mg/dL (5.6 mmol/L) or (c) previously diagnosed type 2 diabetes), (d) hyperlipidemia (triglyceride concentrations ≥150 mg/dL (1.7 mmol/L), or treatment for this lipid abnormality); HDL cholesterol;40 mg/dL (1.03 mmol/L) in males and 50 mg/dL (1.29 mmol/L) in females, or treatment for this lipid abnormality), (e) BMI over 23; and chronic pain or bad mood caused by the psychosomatic disorder for no less than six months
  • have at least 2 of the following distressing symptoms due to psychosomatic or pain and stress symptoms, including physical and mental agitation, feeling tired, often crying, feeling angry/depressed, feeling isolated from family and friends, feeling great stress, insomnia, health is worse than before.

You may not qualify if:

  • non-Chinese nationality or can't speak Cantonese;
  • participating in any cancer treatment;
  • will leave Hong Kong within a short period or the next three months;
  • participating in another experiment; living in or planning to live in a facility-care home;
  • cognitive difficulties (SPMSQ score equal to or lower than 4);
  • taking medications such as estrogenic, synthetic glucocorticoids, anti-steroids, and antiepileptic drugs which may affect cortisol levels.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yan Chai Hospital Social Services Department

Hong Kong, Hong Kong

RECRUITING

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 7, 2024

First Posted

July 15, 2024

Study Start

June 22, 2024

Primary Completion

February 21, 2026

Study Completion (Estimated)

May 21, 2026

Last Updated

July 15, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations